Product Information

DOFETILIDE 125 MCG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1997 per EA under NDC 59651011860. Its NADAC has been published 366 times since Aug 21, 2019.

FDA first approved this application on Jan 22, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOFETILIDE 125 MCG CAPSULE

Dofetilide
$0.1997per EA

Strength

.125 mg/1

NDC

59651011860

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DOFETILIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210740

FDA Approved

1/22/2019

TE Code

AB

On Market Since

1/22/2019

Pharmacological Classes

Price Statistics

The NADAC for DOFETILIDE 125 MCG CAPSULE has been published 366 times since Aug 21, 2019, and over the history we have for it it has declined 93.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1997 per EA
All-time high$3.2150 (Apr 15, 2020)
All-time low$0.1776 (May 22, 2024)
52-week high$0.2198
52-week low$0.1925
Median price$0.5477
Average price$0.8601
Largest weekly change+110.6% (Jan 18, 2023)
Weeks tracked366
Tracking sinceAug 21, 2019

Price History

1W

-0.1%

1M

-0.1%

3M

-2.4%

6M

+3.7%

1Y

-9.0%

3Y

-59.5%

5Y

-77.1%

All

-93.5%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DOFETILIDE 125 MCG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DOFETILIDE 125 MCG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.1997 per EA (NDC 59651011860), effective Aug 19, 2026.

How has the price of DOFETILIDE 125 MCG CAPSULE changed over time?

Over the history we have for it, the NADAC for DOFETILIDE 125 MCG CAPSULE has declined 93.5%. It has been tracked across 366 weekly CMS publications since Aug 21, 2019.

What are the highest and lowest recorded NADAC prices for DOFETILIDE 125 MCG CAPSULE?

Since Aug 21, 2019, the NADAC for DOFETILIDE 125 MCG CAPSULE has ranged from a low of $0.1776 (May 22, 2024) to a high of $3.2150 (Apr 15, 2020), with a median of $0.5477 per EA.

Are there cheaper alternatives to DOFETILIDE 125 MCG CAPSULE?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOFETILIDE 125 MCG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures DOFETILIDE 125 MCG CAPSULE?

DOFETILIDE 125 MCG CAPSULE (NDC 59651011860) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.